Clinical trials
Phase 2 Acute Kidney Injury trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 8 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 12 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
| Recruiting | 21 |
| Terminated | 14 |
| Unknown status | 11 |
| Withdrawn | 8 |
| Not yet recruiting | 4 |
| Suspended | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Action Pharma A/S | 3 |
| Novartis Pharmaceuticals | 3 |
| AbbVie | 2 |
| Arch Biopartners Inc. | 2 |
| Austin Health | 2 |
| Brigham and Women's Hospital | 2 |
| Hospital Civil de Guadalajara | 2 |
| Mayo Clinic | 2 |
| RenaMed Biologics | 2 |
| River 2 Renal Corp. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Kidney Injury | 110 |
| Reperfusion Injury | 6 |
| Sepsis | 6 |
| Critical Illness | 4 |
| Hepatorenal Syndrome | 4 |
| COVID-19 | 3 |
| Fibrosis | 3 |
| Renal Insufficiency | 3 |
| Shock, Septic | 3 |
| Acute Coronary Syndrome | 2 |
Trials
Showing 76 to 100 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.